However, severalcharacteristics of PIK3CA mutations in breast cancer have been observed,including a strong association with expression of the estrogen receptor (ER), a lack ofan association with robust activation of the classical PI3K pathway, as well as arelatively good prognosis for patients with mutations compared with their wild-typecounterparts. This evidence concerns the gene ESR1 and breast cancer.